Form 8-K - Current report:
SEC Accession No. 0001213900-26-051575
Filing Date
2026-05-04
Accepted
2026-05-04 16:05:46
Documents
11
Period of Report
2026-04-30
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0288982-8k_onconetix.htm   iXBRL 8-K 30450
  Complete submission text file 0001213900-26-051575.txt   197665

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE onco-20260430.xsd EX-101.SCH 3017
3 XBRL LABEL FILE onco-20260430_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE onco-20260430_pre.xml EX-101.PRE 22360
14 EXTRACTED XBRL INSTANCE DOCUMENT ea0288982-8k_onconetix_htm.xml XML 3323
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41294 | Film No.: 26937509
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)